Angola vs Peru: New cases tested for RR-/MDR-TB

Angola
93.0%
in 2024
Peru
92.0%
in 2024
Angola rank
84th
Peru rank
87th

New cases tested for RR-/MDR-TB over time

  • Angola
  • Peru
020406080100200620152024

How they compare

Angola currently reports 93.0% against 92.0% in Peru, a difference of 1.0%.

The two have swapped places 3 times across 12 shared years of data; in 2011 it was Peru ahead.

Angola ranks 84th and Peru ranks 87th of 192 countries.

Peru has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Angola Peru Difference Ahead
2010s 12.4% 72.6% 60.2% Peru
2020s 63.7% 83.2% 19.5% Peru

Averages of every year both report within each decade.

Frequently asked questions

Which has higher new cases tested for rr-/mdr-tb, Angola or Peru?
Angola, at 93.0% against 92.0% in Peru as of 2024.
What is the difference in new cases tested for rr-/mdr-tb between Angola and Peru?
1.0%, with Angola ahead.
How many years of comparable data are there for Angola and Peru?
12 years are reported by both, from 2011 to 2024.
How do Angola and Peru rank globally for new cases tested for rr-/mdr-tb?
Angola ranks 84th and Peru ranks 87th of 192 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Angola vs Peru: New cases tested for RR-/MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 30 August 2026, from https://health.statizoid.com/compare/new-cases-tested-for-rr-mdr-tb-percent/angola/peru/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/new-cases-tested-for-rr-mdr-tb-percent/angola/peru/">Angola vs Peru: New cases tested for RR-/MDR-TB</a> — Statizoid

About this data

Indicator
New cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
204 places, 3,368 data points, 2005–2024
Last refreshed